Literature DB >> 11749499

Design and therapeutic application of matrix metalloproteinase inhibitors.

M Whittaker1, C D Floyd, P Brown, A J Gearing.   

Abstract

Year:  1999        PMID： 11749499     DOI： 10.1021/cr9804543

Source DB:  PubMed          Journal:  Chem Rev        ISSN： 0009-2665            Impact factor:   60.622


× No keyword cloud information.
  138 in total

1.  A comparative docking study and the design of potentially selective MMP inhibitors.

Authors:  S Hanessian; N Moitessier; E Therrien
Journal:  J Comput Aided Mol Des       Date:  2001-10       Impact factor: 3.686

2.  Activity-based probes for the proteomic profiling of metalloproteases.

Authors:  Alan Saghatelian; Nadim Jessani; Arul Joseph; Mark Humphrey; Benjamin F Cravatt
Journal:  Proc Natl Acad Sci U S A       Date:  2004-06-25       Impact factor: 11.205

3.  Novel yeast bioassay for high-throughput screening of matrix metalloproteinase inhibitors.

Authors:  Bjoern Diehl; Thorsten M Hoffmann; Nina C Mueller; Jens L Burkhart; Uli Kazmaier; Manfred J Schmitt
Journal:  Appl Environ Microbiol       Date:  2011-10-14       Impact factor: 4.792

4.  Methanethiol Binding Strengths and Deprotonation Energies in Zn(II)-Imidazole Complexes from M05-2X and MP2 Theories: Coordination Number and Geometry Influences Relevant to Zinc Enzymes.

Authors:  Douglas P Linder; Kenton R Rodgers
Journal:  J Phys Chem B       Date:  2015-09-04       Impact factor: 2.991

5.  Identifying chelators for metalloprotein inhibitors using a fragment-based approach.

Authors:  Jennifer A Jacobsen; Jessica L Fullagar; Melissa T Miller; Seth M Cohen
Journal:  J Med Chem       Date:  2010-12-28       Impact factor: 7.446

6.  Heterocyclic zinc-binding groups for use in next-generation matrix metalloproteinase inhibitors: potency, toxicity, and reactivity.

Authors:  David T Puerta; Michael O Griffin; Jana A Lewis; Diego Romero-Perez; Ricardo Garcia; Francisco J Villarreal; Seth M Cohen
Journal:  J Biol Inorg Chem       Date:  2005-12-03       Impact factor: 3.358

7.  Triple-helical transition state analogues: a new class of selective matrix metalloproteinase inhibitors.

Authors:  Janelle Lauer-Fields; Keith Brew; John K Whitehead; Shunzi Li; Robert P Hammer; Gregg B Fields
Journal:  J Am Chem Soc       Date:  2007-08-02       Impact factor: 15.419

8.  Matrix metalloproteinase-inhibitor interaction: the solution structure of the catalytic domain of human matrix metalloproteinase-3 with different inhibitors.

Authors:  Luis A Alcaraz; Lucia Banci; Ivano Bertini; Francesca Cantini; Antonio Donaire; Leonardo Gonnelli
Journal:  J Biol Inorg Chem       Date:  2007-08-21       Impact factor: 3.358

9.  Characterization and regulation of MT1-MMP cell surface-associated activity.

Authors:  Sonia Pahwa; Manishabrata Bhowmick; Sabrina Amar; Jian Cao; Alex Y Strongin; Rafael Fridman; Stephen J Weiss; Gregg B Fields
Journal:  Chem Biol Drug Des       Date:  2018-12-19       Impact factor: 2.817

10.  A macrophage cell model for selective metalloproteinase inhibitor design.

Authors:  Faith E Jacobsen; Matthew W Buczynski; Edward A Dennis; Seth M Cohen
Journal:  Chembiochem       Date:  2008-09-01       Impact factor: 3.164
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.